Drugs aren’t the future of medicine — tiny electric implants are
And pharmaceutical companies seem to agree: for example, GlaxoSmithKline is investing billions in bioelectronic innovation, even offering a $1 million prize to the first team to create a device that can “read and write the body’s electrical language” – by which they mean influence an organ’s function using accurate electrical signals. The US government is also investing in the field through the $250 million SPARC initiative and the ElectRx programme.
Read more: http://mosaicscience.com/extra/bioelectric-dreams#ixzz3c3zj1BCQ